Arcutis Biotherapeutics
Mr. Sukay joined Arcutis as Vice President of Manufacturing and Process Technologies in June 2021. Mr. Sukay joined with over twenty-five years of drug development and operations experience. Prior to joining the company, Mr. Sukay was at Amgen where he held various positions in the U.S. and Asia within Process Development, Clinical and Commercial Manufacturing, as well as Contract Manufacturing. Just prior to joining Arcutis, Mr. Sukay led Amgen’s Contract Development and Manufacturing Organization, responsible for the development and manufacture of multiple clinical and commercial synthetic and biologic drug substances across a global CDMO landscape. Mr. Sukay first started his pharmaceutical career at Roche as a Process Engineer supporting a pipeline of synthetic molecules. Greg earned his B.S. in Chemical Engineering from Purdue University.
This person is not in any offices
Arcutis Biotherapeutics
3 followers
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.